Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 168

  • Unknown sort schema '{last_sort_schema}' ignored
1.

Changing the way we think about wounds: A challenge for 21st century medical practice.

Lusher JM, Murray E, Chapman-Jones D.

Int Wound J. 2018 Apr;15(2):311-312. doi: 10.1111/iwj.12866. Epub 2017 Dec 20. No abstract available.

PMID:
29266777
2.

Complications of haemophilia in babies (first two years of life): a report from the Centers for Disease Control and Prevention Universal Data Collection System.

Kulkarni R, Presley RJ, Lusher JM, Shapiro AD, Gill JC, Manco-Johnson M, Koerper MA, Abshire TC, DiMichele D, Hoots WK, Mathew P, Nugent DJ, Geraghty S, Evatt BL, Soucie JM.

Haemophilia. 2017 Mar;23(2):207-214. doi: 10.1111/hae.13081. Epub 2016 Nov 4.

3.

RELATIONSHIPS BETWEEN BREAST-FEEDING, CO-SLEEPING, AND SOMATIC COMPLAINTS IN EARLY CHILDHOOD.

Peters EM, Lusher JM, Banbury S, Chandler C.

Infant Ment Health J. 2016 Sep;37(5):574-83. doi: 10.1002/imhj.21583. Epub 2016 Aug 23.

PMID:
27552361
4.

Clinical and laboratory variability in a cohort of patients diagnosed with type 1 VWD in the United States.

Flood VH, Christopherson PA, Gill JC, Friedman KD, Haberichter SL, Bellissimo DB, Udani RA, Dasgupta M, Hoffmann RG, Ragni MV, Shapiro AD, Lusher JM, Lentz SR, Abshire TC, Leissinger C, Hoots WK, Manco-Johnson MJ, Gruppo RA, Boggio LN, Montgomery KT, Goodeve AC, James PD, Lillicrap D, Peake IR, Montgomery RR.

Blood. 2016 May 19;127(20):2481-8. doi: 10.1182/blood-2015-10-673681. Epub 2016 Feb 9.

5.

A longer acting rFVIII, safe and effective.

Lusher JM.

Blood. 2014 Jan 16;123(3):304-5. doi: 10.1182/blood-2013-12-539825.

6.

Phenotypes of allo- and autoimmune antibody responses to FVIII characterized by surface plasmon resonance.

Lewis KB, Hughes RJ, Epstein MS, Josephson NC, Kempton CL, Kessler CM, Key NS, Howard TE, Kruse-Jarres R, Lusher JM, Walsh CE, Watts RG, Ettinger RA, Pratt KP; PATH (Personalized Alternative Therapies for Haemophilia) Study Investigators.

PLoS One. 2013 May 8;8(5):e61120. doi: 10.1371/journal.pone.0061120. Print 2013.

7.

No increase in bleeding identified in type 1 VWD subjects with D1472H sequence variation.

Flood VH, Friedman KD, Gill JC, Haberichter SL, Christopherson PA, Branchford BR, Hoffmann RG, Abshire TC, Dunn AL, Di Paola JA, Hoots WK, Brown DL, Leissinger C, Lusher JM, Ragni MV, Shapiro AD, Montgomery RR.

Blood. 2013 May 2;121(18):3742-4. doi: 10.1182/blood-2012-12-471672. Epub 2013 Mar 21.

8.

Emergency department visits in children with hemophilia.

Özgönenel B, Zia A, Callaghan MU, Chitlur M, Rajpurkar M, Lusher JM.

Pediatr Blood Cancer. 2013 Jul;60(7):1188-91. doi: 10.1002/pbc.24401. Epub 2012 Nov 28.

9.

Development and introduction of recombinant factor VIII--a clinician's experience.

Lusher JM.

Haemophilia. 2012 Jul;18(4):483-6. doi: 10.1111/j.1365-2516.2012.02804.x. Epub 2012 Apr 19. Review. No abstract available.

PMID:
22512315
10.

VWF mutations and new sequence variations identified in healthy controls are more frequent in the African-American population.

Bellissimo DB, Christopherson PA, Flood VH, Gill JC, Friedman KD, Haberichter SL, Shapiro AD, Abshire TC, Leissinger C, Hoots WK, Lusher JM, Ragni MV, Montgomery RR.

Blood. 2012 Mar 1;119(9):2135-40. doi: 10.1182/blood-2011-10-384610. Epub 2011 Dec 23.

11.

A community-based partnership to promote information infrastructure for bleeding disorders.

Aschman DJ, Abshire TC, Shapiro AD, Lusher JM, Forsberg AD, Kulkarni R.

Am J Prev Med. 2011 Dec;41(6 Suppl 4):S332-7. doi: 10.1016/j.amepre.2011.09.018.

PMID:
22099355
12.

Fibrinolytic parameters in children with noncatheter thrombosis: a pilot study.

Kupesiz OA, Chitlur MB, Hollon W, Tosun O, Thomas R, Warrier I, Lusher JM, Rajpurkar M.

Blood Coagul Fibrinolysis. 2010 Jun;21(4):313-9. doi: 10.1097/MBC.0b013e32833464ce.

PMID:
20305541
13.

Common VWF exon 28 polymorphisms in African Americans affecting the VWF activity assay by ristocetin cofactor.

Flood VH, Gill JC, Morateck PA, Christopherson PA, Friedman KD, Haberichter SL, Branchford BR, Hoffmann RG, Abshire TC, Di Paola JA, Hoots WK, Leissinger C, Lusher JM, Ragni MV, Shapiro AD, Montgomery RR.

Blood. 2010 Jul 15;116(2):280-6. doi: 10.1182/blood-2009-10-249102. Epub 2010 Mar 15.

14.

Evolution of recombinant factor VIII safety: KOGENATE and Kogenate FS/Bayer.

Lusher JM, Scharrer I.

Int J Hematol. 2009 Nov;90(4):446-454. doi: 10.1007/s12185-009-0435-x. Epub 2009 Nov 3. Review.

PMID:
19882376
15.

Ethanol lock therapy for the treatment of catheter-related infections in haemophilia patients.

Rajpurkar M, Boldt-Macdonald K, McLenon R, Callaghan MU, Chitlur M, Lusher JM, Becker C.

Haemophilia. 2009 Nov;15(6):1267-71. doi: 10.1111/j.1365-2516.2009.02075.x. Epub 2009 Jul 29.

PMID:
19659937
16.

Inhibitors in factor IX deficiency a report of the ISTH-SSC international FIX inhibitor registry (1997-2006).

Chitlur M, Warrier I, Rajpurkar M, Lusher JM.

Haemophilia. 2009 Sep;15(5):1027-31. doi: 10.1111/j.1365-2516.2009.02039.x. Epub 2009 Jun 10.

PMID:
19515028
17.

Decreased clearance of von Willebrand factor in a patient with type 2B von Willebrand disease following development of immune thrombocytopenia.

Wang ZJ, Onwuzurike N, Callaghan MU, Rajpurkar M, Chitlur M, Lusher JM.

Pediatr Blood Cancer. 2008 Sep;51(3):416-8. doi: 10.1002/pbc.21593.

18.

Thromboelastography in children with coagulation factor deficiencies.

Chitlur M, Warrier I, Rajpurkar M, Hollon W, Llanto L, Wiseman C, Lusher JM.

Br J Haematol. 2008 Jun;142(2):250-6. doi: 10.1111/j.1365-2141.2008.07063.x. Epub 2008 May 19.

PMID:
18492116
19.

Recombinant clotting factors: a review of current clinical status.

Lusher JM.

BioDrugs. 2000 Apr;13(4):289-98.

PMID:
18034535
20.

Recombinant factor VIIa: a viewpoint by Jeanne M. Lusher.

Lusher JM.

BioDrugs. 1999 Jul;12(1):78-9. No abstract available.

PMID:
18031165

Supplemental Content

Loading ...
Support Center